心房颤动负荷:超越房颤作为二元实体的科学声明
该科学声明基于文献综述,讨论房颤负荷的定义与测量方法、其与心血管和神经结局的关系,以及生活方式和危险因素干预对房颤负荷的影响。现有指南对不论房颤模式或负荷均给予相同抗凝推荐,但近期证据提示更高房颤负荷与更高卒中风险相关,阈值尚未明确。结构化的危险因素管理项目可能有效降低房颤负荷。
要点
- 房颤负荷可定量定义为最长持续时间、监测期间房颤发作次数及处于房颤的时间比例。
- 更高房颤负荷与更高卒中风险相关,但风险是否连续增加或存在阈值尚不明确。
- 结构化危险因素管理(控制危险因素、减重、维持健康体重)可能有效降低房颤负荷。
核心结论
- 更高房颤负荷与更高卒中、心力衰竭和死亡风险相关,但风险增加是否连续或存在阈值尚未明确。
- 结构化危险因素管理项目可能有效降低房颤负荷。
研究设计与样本
- 美国心脏协会科学声明,基于已发表文献综述,讨论房颤负荷的定义与测量、与结局的关系及危险因素干预效果。
主要发现
- 许多研究按房颤类型(阵发性与非阵发性)分类分析结局,但房颤负荷可定量定义为最长持续时间、监测期间发作次数及处于房颤的时间比例。
- 当前指南对不论房颤模式或负荷均给予相同抗凝推荐,但近期证据提示更高房颤负荷与更高卒中风险相关。
- 更高房颤负荷还与更高心力衰竭患病率和发病率及更高死亡风险相关,但不一定与更低生活质量相关。
- 结构化综合危险因素管理项目针对危险因素、减重和维持健康体重,似乎有效降低房颤负荷。
关键数值与推荐
- 当前指南对不论房颤模式或负荷均给予相同抗凝推荐。
- 房颤负荷可定量定义为最长持续时间、监测期间房颤发作次数及处于房颤的时间比例(以百分比表示)。
临床怎么用
- 临床应关注房颤负荷的定量评估,而非仅按房颤有无或类型分类。
- 对房颤患者可考虑结构化危险因素管理(控制危险因素、减重、维持健康体重)以降低房颤负荷。
- 抗凝决策目前仍遵循指南对不论房颤模式或负荷的相同推荐,但需关注房颤负荷与卒中风险的证据进展。
局限性
- 房颤负荷的定义和测量方法有待验证。
- 导致卒中风险增加的房颤负荷阈值尚未确定。
- 房颤与卒中弱时间相关性的机制尚不清楚。
- 监测技术的发展可能改变长期房颤监测的格局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Our understanding of the risk factors and complications of atrial fibrillation (AF) is based mostly on studies that have evaluated AF in a binary fashion (present or absent) and have not investigated AF burden. This scientific statement discusses the published literature and knowledge gaps related to methods of defining and measuring AF burden, the relationship of AF burden to cardiovascular and neurological outcomes, and the effect of lifestyle and risk factor modification on AF burden. Many studies examine outcomes by AF burden classified by AF type (paroxysmal versus nonparoxysmal); however, quantitatively, AF burden can be defined by longest duration, number of AF episodes during a monitoring period, and the proportion of time an individual is in AF during a monitoring period (expressed as a percentage). Current guidelines make identical recommendations for anticoagulation regardless of AF pattern or burden; however, a review of recent evidence suggests that higher AF burden is associated with higher risk of stroke. It is unclear whether the risk increases continuously or whether a threshold exists; if a threshold exists, it has not been defined. Higher burden of AF is also associated with higher prevalence and incidence of heart failure and higher risk of mortality, but not necessarily lower quality of life. A structured and comprehensive risk factor management program targeting risk factors, weight loss, and maintenance of a healthy weight appears to be effective in reducing AF burden. Despite this growing understanding of AF burden, research is needed into validation of definitions and measures of AF burden, determination of the threshold of AF burden that results in an increased risk of stroke that warrants anticoagulation, and discovery of the mechanisms underlying the weak temporal correlations of AF and stroke. Moreover, developments in monitoring technologies will likely change the landscape of long-term AF monitoring and could allow better definition of the significance of changes in AF burden over time.
引用
- Chen LY, Chung MK, Allen LA, et al. Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association. Circulation. 2018. PMID: 29661944. doi:10.1161/CIR.0000000000000568
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。